title: Editorial: Food and Drug Administration Safety Communication on rhBMP-2 use.
authors: Division of Pediatric Neurosurgery, University of Utah, Salt Lake City, Utah.
authors: John R W
authors: JR
authors: Kestle
mesh_terms: D055396:Bone Morphogenetic Protein 2 / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000453:epidemiology*; D013123:Spinal Fusion / Q000379:methods*; D016212:Transforming Growth Factor beta / Q000627:therapeutic use*
chemical_list: D055396:Bone Morphogenetic Protein 2; D016212:Transforming Growth Factor beta